External Funding » Cancer Center » UF Health Cancer Center

Updated: August 2020

Coming Soon

Centers for Disease Control and Prevention (CDC)
Reducing Inequities in Cancer Outcomes through Community-Based Interventions on Social Determinants of Health

Featured cancer-focused external funding opportunities:

Sponsor	Title	Due Date	Category	Type
Pfizer	NCCN / Pfizer: Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer	08/12/2020	Non-Limited	Research
Pfizer	Pfizer: Prostate Cancer Disparities Project	08/13/2020	Non-Limited	Research
National Institutes of Health (NIH)	NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)	08/21/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Pancreatic Cancer, Idea Development Award	08/25/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Pancreatic Cancer, Translational Research Partnership Award	08/25/2020	Non-Limited	Research
National Organization for Rare Disorders (NORD)	National Organization for Rare Disorders Invites Proposals for Studies of PMP, NEHI	08/25/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Prostate Cancer, Idea Development Award	08/27/2020	Non-Limited	Research
Multiple Myeloma Research Foundation (MMRF)	Multiple Myeloma Research Foundation (MMRF):2020 Research Fellow Award	08/28/2020	Non-Limited	Training/Career
Elsa U. Pardee Foundation	Cancer Res Pardee Foundation: Proposals for Cancer Researchearch Grants	08/31/2020	Non-Limited	Research
American Association for Cancer Research (AACR)	American Association for Cancer: AACR Clinical Oncology Research (CORE) Training Fellowships	08/31/2020	Non-Limited	Training/Career
Department of Defense (DOD)	DoD Kidney Cancer, Clinical Consortium – Clinical Trial Site Award	09/02/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Kidney Cancer, Idea Development Award	09/02/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Kidney Cancer, Postdoctoral and Clinical Fellowship Award	09/02/2020	Non-Limited	Research
National Institutes of Health (NIH)	Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)	09/07/2020	Non-Limited	Research
National Institutes of Health (NIH)	Co-infection and Cancer (R01 Clinical Trial Not Allowed)	09/07/2020	Non-Limited	Research
National Cancer Institute (NCI)	National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)	09/07/2020 09/25/2020	Non-Limited	Research
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)	09/07/2020 10/12/2020 01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)	09/07/2020 10/16/2020	Non-Limited	Research
National Cancer Institute (NCI)	NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)	09/07/2020 10/20/2020	Non-Limited	Research
Department of Defense (DOD)	DoD, Breast Cancer, Breakthrough Award Levels 1 and 2	09/08/2020	Non-Limited	Research
Department of Defense (DOD)	DoD, Breast Cancer, Era of Hope Scholar Award	09/08/2020	Non-Limited	Research
Pfizer	NCCN/Pfizer: Adoption of Biosimilars in Oncology	09/09/2020	Non-Limited	Research
Lymphoma Research Foundation (LRF)	Lymphoma Research Foundation: Scientific Research Mentoring Program	09/09/2020	Non-Limited	Training/Career
Lymphoma Research Foundation (LRF)	Lymphoma Research Foundation: Clinical Investigator Career Development Award (2021-2024)	09/09/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award	09/10/2020	Non-Limited	Research
Pfizer	Pfizer: Addressing Racial Disparities in Cancer Care	09/10/2020	Non-Limited	Research
National Cancer Institute (NCI)	National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)	09/25/2020	Non-Limited	Research
National Cancer Institute (NCI)	Metastasis Research Network (U54 Clinical Trial Not Allowed)	09/28/2020 05/28/2021	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Cancer Institute (NCI)	Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)	09/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)	09/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)	09/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)	09/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)	09/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)	09/30/2020	Non-Limited	Research
Cancer Research Institute (CRI)	Cancer Research Institute: CRI Irvington Postdoctoral Fellowship Program	10/01/2020	Non-Limited	Training/Career
Mike Slive Foundation	The Mike Slive Foundation for Prostate Cancer Research	10/01/2020	Non-Limited	Research
National Institutes of Health (NIH)	Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)	10/05/2020	Non-Limited	Research
National Institutes of Health (NIH)	Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)	10/05/2020	Non-Limited	Research
National Institutes of Health (NIH)	Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)	10/05/2020	Non-Limited	Research
National Institutes of Health (NIH)	Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)	10/05/2020 02/05/2021	Non-Limited	Research
National Institutes of Health (NIH)	Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)	10/08/2020	Non-Limited	Research
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)	10/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)	10/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)	10/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)	10/14/2020	Non-Limited	Research
National Institutes of Health (NIH)	Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)	10/14/2020	Non-Limited	Research
National Institutes of Health (NIH)	Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)	10/14/2020	Non-Limited	Research
National Institutes of Health (NIH)	Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)	10/14/2020	Non-Limited	Research
American Cancer Society	RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services	10/15/2020	Non-Limited	Research
Department of Defense (DOD)	CDMRP Peer Reviewed Medical Research Program Investigator-Initiated Research Award	10/15/2020	Non-Limited	Research
National Institutes of Health (NIH)	Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)	10/16/2020	Non-Limited	Research
American Cancer Society	Clinician Scientist Development Grant (CSDG)	10/16/2020	Non-Limited	Research
National Institutes of Health (NIH)	Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)	10/16/2020 02/16/2021	Non-Limited	Research
National Cancer Institute (NCI)	NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)	10/20/2020 12/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)	10/21/2020	Non-Limited	Research
National Institutes of Health (NIH)	Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)	10/21/2020	Non-Limited	Research
Melanoma Research Alliance (MRA)	Melanoma Research Alliance and St. Baldrick’s Foundation: Young Investigator Awards in Pediatric Melanoma	10/21/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (P50 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (U54 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)	10/27/2020 02/17/2021	Non-Limited	Research
Cancer Research Institute (CRI)	Cancer Research Institute: Clinic & Laboratory Integration Program (CLIP)	11/01/2020	Non-Limited	Research
Melanoma Research Alliance (MRA)	Melanoma Research Alliance and St. Baldrick’s Foundation: Young Investigator Awards in Pediatric Melanoma	11/04/2020	Non-Limited	Research
National Institutes of Health (NIH)	Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed)	11/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)	11/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)	11/15/2020	Non-Limited	Research
National Institutes of Health (NIH)	Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Cancer Institute (NCI)	Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Cancer Institute (NCI)	Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Institutes of Health (NIH)	Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)	11/19/2020	Non-Limited	Research
National Institutes of Health (NIH)	Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)	12/10/2020	Non-Limited	Research
Alexs Lemonade Stand Foundation (ALSF)	Alex’s Lemonade Stand Foundation (ALSF) and RUNX1 Research Program (RRP) Early Career Investigator Grant	12/16/2020	Non-Limited	Research
B*Cured	Brain Cancer Research Investigator Grant	04/01/2021	Non-Limited	Research
National Institutes of Health (NIH)	Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)	06/17/2021	Non-Limited	Research